Research
We are driving the next generation of discoveries to address critical cancer challenges and accelerate the translation of scientific evidence into patient benefit.
Education
Fostering an outstanding cancer care workforce to help maintain and enhance world-leading patient outcomes through online learning, courses and events.
Health Equity
Pursuing equity in access to cancer care and outcomes for all Victorians affected by cancer.
Consumer Engagement
Partnering with consumers at every step of our journey, because no-one knows cancer like someone who’s lived it.
About Us
Research, academic and clinical institutions working together to accelerate cancer research, knowledge and expertise to benefit all.
News & Events
The VCCC Alliance brings you the latest in cancer research, education and clinical care through engaging, relevant and informative events.

Monday Lunch Livestream with Professor Louise Purton

Key roles of Hoxa1 in HSCs and myelodysplastic syndromes

Myelodysplastic syndromes (MDS) is a malignant blood cell disease that predominantly results in bone marrow failure, where patients die from complications relating to low blood cell counts. It is a heterogeneous disease and approximately thirty percent of patients progress to acute myeloid leukaemia. Aside from stem cell transplants, which most patients are ineligible for due to their older age, there is no cure.

Hear from Professor Louise Purton (Head, Stem Cell Regulation Unit, St Vincent’s Institute of Medical Research), who will review the role of the altered HOXA1 gene in MDS and how it affects the ability of HSCs to form blood cells. Her presentation will explore how mouse models of MDS with altered HOXA1 expression can be used to understand what changes occur in the HSCs to cause MDS, identify targets and improve therapeutic options for patients suffering from this disease.

Louise Purton head shot 2018

Professor Louise Purton

Professor Louise Purton established and is Head of the Stem Cell Regulation Unit at St Vincent’s Institute of Medical Research. Her research involves how haematopoiesis is regulated both intrinsically and extrinsically in normal and diseased states. Louise has a passion for translational research and to date, her research has resulted in four clinical trials. She is internationally recognised and has received funding from numerous national and international funding bodies including; NHMRC, NIH, Leukaemia and Lymphoma Society of America (LLSA), Worldwide Cancer Research. Additionally, she has held Fellowships from NHMRC and LLSA.

Monday 22 March
1-2pm

Get the latest in cancer news, events and more, direct to your inbox

Join a network of Victorian cancer researchers, clinicians and consumers to keep your finger on the pulse.